Nicholas Rebold

Clinical Assistant Professor

Howard University

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Nicholas Rebold is a Clinical Assistant Professor at Howard University in the United States. His research focuses on pharmacotherapy for multidrug-resistant infections, including studies on sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists. He has contributed to multiple articles addressing therapeutic strategies for drug-resistant pathogens and the clinical implications of antibiotic use in various infections.

Articles (9)

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

UNITED STATES

View details

Ashlan J Kunz Coyne

Assistant Professor

University of Kentucky College of Pharmacy

UNITED STATES

View details

Dhakrit Rungkitwattanakul

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Nicholas Rebold

Research Interests

Explore related searches

Contact this professor

About

Articles (9)

Real-World Applications of Imipenem-Cilastatin-Relebactam: Insights From a Multicenter Observational Cohort Study

Factors and Disparities Influencing Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-like Peptide 1 Receptor Agonists Initiation in the United States: A Scoping Review of Evidence

Updates in pulmonary drug‐resistant tuberculosis pharmacotherapy: A focus on BPaL and BPaLM

High-dose Cefepime vs Carbapenems for Bacteremia Caused by Enterobacterales with Moderate to High Risk of Clinically Significant AmpC β-lactamase Production

Risk Factors for Carbapenem-Resistant Enterobacterales Clinical Treatment Failure

Oral stepdown in Gram‐positive bloodstream infections: A step in the right direction

Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa

Panacea or oversimplification: Relating AUC and troughs

Early Multicenter Experience With Imipenem-Cilastatin-Relebactam for Multidrug-Resistant Gram-Negative Infections

Collaborators (7)

Dana Holger

Travis Carlson

Amer El Ghali

Michael Veve

Kevin W. Garey

Ashlan J Kunz Coyne

Dhakrit Rungkitwattanakul

Make your next move.